Skip to main navigation
logo

Investor Relations

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Code of Business Conduct and Compliance Hotline
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

14 01 / 2025
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring revenue expected to be approximately $4.2 million, representing growth of approximately 27% compared to
07 01 / 2025
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products,

Featured Pages

Stock Information
Stock Information
Governance
Governance
SEC Filings
SEC Filings
FAQs
FAQs

Investor Tools

  • RSS Feeds
  • Print Page
  • Email Alerts
  • Contact IR

© 2025 Rapid Micro Biosystems, Inc.     All rights reserved.